Laboratory research material

MOTS-C 40mg

£39.99

MOTS-C 40mg (mitochondrial-derived peptide MOTS-c, also written MOTSc, CAS 1627580-64-6) supplied as a lyophilised powder in a single sealed vial for laboratory research. The larger format, for extended studies and multi-assay designs run from one batch. Janoshik report published for this format. For in-vitro research use only.

Research guide: What Is MOTS-C? · Smaller format: MOTS-C 10mg

  • Same working-day dispatch on in-stock orders before 3pm, Mon–Fri
  • Royal Mail Tracked 24, free UK delivery on orders of £50 or more
  • Certificates of analysis published on our CoA page
  • Laboratory research use only; 18+ to purchase
Key Features
  • Form: Lyophilised peptide powder
  • Quantity: 1 sealed vial, 40mg labelled
  • Compound: MOTS-c, 16-amino-acid mitochondrial-derived peptide (CAS 1627580-64-6)
  • Intended use: Laboratory research only

Safety information: Not intended for human or veterinary use. Use appropriate laboratory safety procedures when handling.

MOTS-C 40mg should only be used in laboratory settings by qualified personnel.

Ensure all experimental procedures comply with local and institutional regulations.

This peptide is supplied for research and scientific study purposes only.

Janoshik test #125392 was run on one vial labelled MOTS-C 40mg from batch 20260114, analysis dated 7 April 2026. It reported a purity of 99.391% and a measured MOTS-c content of 43.66 mg for that vial. View the report on janoshik.com (verification key IKFY5JSKQTKY).

Purity and measured content are different results: purity is the share of detected material that is MOTS-c, and does not by itself establish quantity. The report covers one vial; it does not show that every vial or batch gives the same result, and whether the batch reference identifies a production batch matching current stock is still being confirmed. The report does not state the analytical method. It applies to the 40mg format only and does not verify 10mg vials.

Product Details

MOTS-C 40mg

MOTS-C 40mg is the larger vial of MOTS-c, a 16-amino-acid peptide encoded by a short open reading frame in the mitochondrial 12S rRNA gene. Ascend Peptides UK supplies it as a lyophilised powder in a sealed vial for laboratory research only. It suits larger single-batch studies than the MOTS-C 10mg vial.

At a glance

  • ProductMOTS-C 40mg, Ascend Peptides UK
  • CompoundMOTS-c (mitochondrial open reading frame of the 12S rRNA type-c)
  • SequenceMRWQEMGYIFYPRKLR (16 amino acids)
  • Quantity40mg per vial (labelled)
  • FormLyophilised powder, single sealed vial
  • Molecular formulaC101H152N28O22S2 (peptide, free form)
  • Molecular weight2174.6 g/mol
  • CAS number1627580-64-6
  • IdentifiersUNII A5CV6JFB78; PubChem CID 146675088; UniProt A0A0C5B5G6
  • Certificate (40mg)Janoshik report published (see the CoA page)
  • Intended purposeLaboratory research only
  • CategoryMetabolic research peptides

MOTS-C 10mg or 40mg?

Both vials contain the same peptide. The 40mg vial suits larger experimental designs, longer studies and work where several assays should draw on one vial and one batch. The MOTS-C 10mg vial suits pilot work and method development. Of the two formats, only the 40mg vial has a published certificate.

MOTS-c in Laboratory Research

MOTS-c was described in 2015 as a peptide encoded within the mitochondrial 12S rRNA. In cell and mouse studies it inhibited the folate cycle and de novo purine synthesis, which led to AMPK activation, and its main target tissue appeared to be skeletal muscle (Lee et al., 2015). Later cell work reported that MOTS-c moves to the nucleus under metabolic stress, in an AMPK-dependent way, and regulates nuclear genes (Kim et al., 2018). In mice, MOTS-c treatment was reported to improve physical performance; in humans, the same study measured higher endogenous MOTS-c after exercise but did not give MOTS-c to people (Reynolds et al., 2021).

These are findings about the compound in the published literature, mainly from cell and animal models. They are not properties tested on this product and do not describe any outcome in humans. A fuller explanation is in What Is MOTS-C?

Testing and Documentation

A Janoshik report for one tested vial of MOTS-C 40mg is published on the CoA page, where the batch reference, results and verification details for that vial are listed.

Purity and content are different results. Purity is the share of detected material that is MOTS-c. Content is how much MOTS-c was measured in the vial. Each report covers one vial from one batch: it does not show that every vial or batch gives the same result, and whether a report’s batch reference identifies a production batch, and matches current stock, is still being confirmed with the manufacturer. The report does not state the analytical method used and lists no separate mass-spectrometry identity test.

The identifiers above (sequence, formula, molecular weight, CAS, UNII, PubChem and UniProt numbers) are reference values for the MOTS-c peptide from PubChem, the NCATS substance registry and UniProt. They describe the compound, not test results for a particular vial, and they refer to the free peptide; the salt form supplied (for example acetate or trifluoroacetate) has not yet been confirmed by the manufacturer.

Storage and Handling

Storage requirements for this product are being verified with the manufacturer. Please contact ASCEND before purchasing for information about the current product batch.

References

  • Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. PubMed 25738459
  • Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018;28(3):516–524.e7. PubMed 29983246
  • Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. PubMed 33473109
  • Mitochondria-derived peptide MOTS-c substance record, UNII A5CV6JFB78: sequence and formula C101H152N28O22S2. NCATS Global Substance Registration System. GSRS A5CV6JFB78
  • MOTS-c compound record, CID 146675088: molecular weight 2174.6 g/mol. PubChem. PubChem 146675088
Disclaimer

For in-vitro laboratory research only. Not for human consumption. Not an MHRA-licensed medicine.

Research Use Only

MOTS-C 40mg is supplied strictly for in-vitro laboratory research and not for human use. It is not a medicine, is not an MHRA-licensed product, and is not supplied or marketed for diagnostic, therapeutic or clinical use in humans or animals. MOTS-c is prohibited at all times under the World Anti-Doping Agency Prohibited List, where it is named under S4.4.1 (AMPK activators).

More Research Materials

Other laboratory research materials supplied by Ascend Peptides UK.

Acetic Acid 10ml research solvent vial

Acetic Acid 10ml

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML

Bacteriostatic Water 10ml research solvent vial

Bacteriostatic Water 10ml

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML

MOTS-C 40mg UK research peptide vial

MOTS-C 40mg

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML

MOTS-C 10mg UK research peptide vial

MOTS-C 10mg

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML